ProCE Banner Activity

TRK Inhibitor Resistance and Safety

Slideset Download
Download this slideset for expert perspectives on emerging next-generation TRK inhibitors and their potential use in managing resistance to first-generation agents, as well key adverse events with TRK inhibitors and management strategies.

Released: July 10, 2020

Expiration: July 09, 2021

Share

Faculty

Alexander E. Drilon

Alexander E. Drilon, MD

Chief, Early Drug Development Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Genentech TEXT Only

Faculty Disclosure

Primary Author

Alexander E. Drilon, MD

Chief, Early Drug Development Service
Memorial Sloan Kettering Cancer Center
New York, New York